Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Health Sciences profile

Associate Professor Yoram Barak

PositionConsultant Psychogeriatrician
DepartmentDepartment of Psychological Medicine (DSM)
QualificationsMD MHA
Research summaryPrevention, assessment, and treatment of late-life psychiatric disorders

Yoram Barak is an Associate Professor of Psychiatry and Consultant Psychogeriatrician. He trained in medicine and psychiatry at the Sackler School of Medicine. In 1993 he became an Israel Medical Scientific Council Specialist in Psychiatry, and in 2004 was awarded a Masters in Health Administration from Ben-Gurion University, Beer-Sheva, Israel.

A consultant for the National Multiple Sclerosis Center in Israel, he is also a special consultant on positive psychology for the Israel Defense Forces. Past president of the Israeli Association of Old-Age Psychiatry, and is on the editorial board of the Israel Journal of Psychiatry and the Open Psychiatry Journal.


Associate Professor Barak’s research interests include multiple sclerosis, cancer, a wide range of psychiatric conditions (such as depression, schizophrenia, and obsessive–compulsive disorder), old-age psychiatry, and suicide.

He has published extensively in these areas, and is author or co-author of over 150 peer-reviewed journal articles. His book "Preventing Alzheimer's Disease" has recently been published in the US.


Briskman, I., Shelef, A., Berger, U., Baruch, Y., Bar, G., Asherov, J., … Barak, Y. (2017). Deliberate self-harm in older adults: A general hospital emergency department survey. Israel Medical Association Journal, 19(3), 160-163.

Tzvieli, A., Zaig, T., Ayal, I., Thieberger, G., Rothschild, S., & Barak, Y. (2017). The impact of self-directed Voice of Love messages on anger: A pilot study. Advances in Mind-Body Medicine, 31(2), 12-15.

Rothschild, S., Kaplan, G., Golan, T., & Barak, Y. (2017). Mindfulness meditation in the Israel Defense Forces: Effect on cognition and satisfaction with life: A randomized controlled trial. European Journal of Integrative Medicine, 10, 71-74. doi: 10.1016/j.eujim.2017.01.010

Barak, Y., & Fridman, D. (2017). Impact of Mediterranean diet on cancer: Focused literature review. Cancer Geonomics & Proteomics, 14(6), 403-408. doi: 10.21873/cgp.20050

Croucher, M., Plopsky, I., Pridan, S., & Barak, Y. (2017). Treatment options for psychotic depression in older people: Focused literature review by New Zealand Psychogeriatric Team. Annals of Psychiatry & Mental Health, 5(1), 1094.

Journal - Research Article

Briskman, I., Shelef, A., Berger, U., Baruch, Y., Bar, G., Asherov, J., … Barak, Y. (2017). Deliberate self-harm in older adults: A general hospital emergency department survey. Israel Medical Association Journal, 19(3), 160-163.

Barak, Y., & Fridman, D. (2017). Impact of Mediterranean diet on cancer: Focused literature review. Cancer Geonomics & Proteomics, 14(6), 403-408. doi: 10.21873/cgp.20050

Rothschild, S., Kaplan, G., Golan, T., & Barak, Y. (2017). Mindfulness meditation in the Israel Defense Forces: Effect on cognition and satisfaction with life: A randomized controlled trial. European Journal of Integrative Medicine, 10, 71-74. doi: 10.1016/j.eujim.2017.01.010

Tzvieli, A., Zaig, T., Ayal, I., Thieberger, G., Rothschild, S., & Barak, Y. (2017). The impact of self-directed Voice of Love messages on anger: A pilot study. Advances in Mind-Body Medicine, 31(2), 12-15.

Barak, Y., Finkelstein, I., & Pridan, S. (2016). The geriatric mania asenapine study (GeMS). Archives of Gerontology & Geriatrics, 64, 111-114. doi: 10.1016/j.archger.2016.01.012

Pridan, S., Swartz, M., Baruch, Y., Tadger, S., Plopski, I., & Barak, Y. (2015). Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia. International Psychogeriatrics, 27(1), 131-134. doi: 10.1017/s1041610214001756

Shelef, A., Zdaka, C., & Barak, Y. (2015). Happiness amongst Israel Defense Force (IDF) Mental Health Officers (MHO’s). Disaster & Military Medicine, 1(7). doi: 10.1186/2054-314X-1-7

Shelef, A., Mazeh, D., Berger, U., Baruch, Y., & Barak, Y. (2015). Acute electroconvulsive therapy followed by maintenance electroconvulsive therapy decreases hospital re-admission rates of older patients with severe mental illness. Journal of ECT, 31(2), 125-128. doi: 10.1097/yct.0000000000000197

Kertesz, D. P., Swartz, M. V., Tadger, S., Plopski, I., & Barak, Y. (2015). Tetrabenazine for tardive tremor in elderly adults: A prospective follow-up study. Clinical Neuropharmacology, 38(1), 23-25. doi: 10.1097/wnf.0000000000000061

Valencia, M., Fresán, A., Barak, Y., Juárez, F., Escamilla, R., & Saracco, R. (2015). Predicting functional remission in patients with schizophrenia: A cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome. Neuropsychiatric Disease & Treatment, 11, 2339-2348. doi: 10.2147/ndt.s87335

Achiron, A., Givon, U., Magalashvili, D., Dolev, M., Zaltzman, S. L., Kalron, A., … Barak, Y. (2015). Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study. Multiple Sclerosis Journal, 21(6), 767-775. doi: 10.1177/1352458514554053

Klang, S. H., Ben-Amnon, Y., Cohen, Y., & Barak, Y. (2015). Community pharmacists' support improves antidepressant adherence in the community. International Clinical Psychopharmacology, 30(6), 316-319. doi: 10.1097/yic.0000000000000090

Or, A., Baruch, Y., Tadger, S., & Barak, Y. (2014). Real-life decision making of Serious Mental Illness patients: Opt-in and opt-out research participation. Israel Journal of Psychiatry & Related Sciences, 51(3), 199-203.

Shelef, A., Hiss, J., Cherkashin, G., Berger, U., Aizenberg, D., Baruch, Y., & Barak, Y. (2014). Psychosocial and medical aspects of older suicide completers in Israel: A 10-year survey. International Journal of Geriatric Psychiatry, 29(8), 846-851. doi: 10.1002/gps.4070

Ohana, I., Golander, H., & Barak, Y. (2014). Balancing psychache and resilience in aging Holocaust survivors. International Psychogeriatrics, 26(6), 929-934. doi: 10.1017/s104161021400012x

Raviv, G., Laufer, M., Baruch, Y., & Barak, Y. (2014). Risk of prostate cancer in patients with schizophrenia. Comprehensive Psychiatry, 55(7), 1639-1642. doi: 10.1016/j.comppsych.2014.05.007

Nehama, Y., Rabinowitz, I., Baruch, Y., Mandel, A., Lurie, I., & Barak, Y. (2014). Debunking the placebo effect in depression: The effect of patient and investigator expectation on escitalopram efficacy. International Clinical Psychopharmacology, 29(2), 106-110. doi: 10.1097/yic.0000000000000013

Achiron, A., Chapman, J., Magalashvili, D., Dolev, M., Lavie, M., Bercovich, E., … Barak, Y. (2013). Modeling of cognitive impairment by disease duration in multiple sclerosis: A cross-sectional study. PLoS ONE, 8(8), e71058. doi: 10.1371/journal.pone.0071058

Bergman, Y., & Barak, Y. (2013). Escitalopram for antipsychotic nonresponsive visual hallucinosis: Eight patients suffering from Charles Bonnet syndrome. International Psychogeriatrics, 25(9), 1433-1436. doi: 10.1017/s1041610213000719

Barak, Y., & Aizenberg, D. (2012). Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment. BMC Psychiatry, 12, 108. doi: 10.1186/1471-244x-12-108

Barak, Y., & Aizenberg, D. (2011). Switching to aripiprazole as a strategy for weight reduction: A meta-analysis in patients suffering from schizophrenia. Journal of Obesity, 2011, 898013. doi: 10.1155/2011/898013

Tadger, S., Paleacu, D., & Barak, Y. (2011). Quetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: A retrospective chart review. Archives of Gerontology & Geriatrics, 53(1), 104-105. doi: 10.1016/j.archger.2010.06.012

Ohanna, I., Golander, H., & Barak, Y. (2011). Does late onset depression predispose to dementia? A retrospective, case-controlled study. Comprehensive Psychiatry, 52(6), 659-661. doi: 10.1016/j.comppsych.2010.10.016

Barak, Y., Plopski, I., Tadger, S., & Paleacu, D. (2011). Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: A randomized double-blind pilot study. International Psychogeriatrics, 23(9), 1515-1519. doi: 10.1017/s1041610211000743

Barak, Y., Levy, D., Szor, H., & Aizenberg, D. (2011). First-onset functional brief psychoses in the elderly. Canadian Geriatrics Journal, 14(2), 30-33.

Levy, T. B., Barak, Y., Sigler, M., & Aizenberg, D. (2011). Suicide attempts and burden of physical illness among depressed elderly inpatients. Archives of Gerontology & Geriatrics, 52(1), 115-117. doi: 10.1016/j.archger.2010.02.012

Barak, Y., Swartz, M., & Baruch, Y. (2011). Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: A retrospective analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(7), 1744-1747. doi: 10.1016/j.pnpbp.2011.06.007

Briskman, I., Dubinski, R., & Barak, Y. (2010). Treating delirium in a general hospital: A descriptive study of prescribing patterns and outcomes. International Psychogeriatrics, 22(2), 328-331. doi: 10.1017/s1041610209990986

Barak, Y., & Aizenberg, D. (2010). Is dementia preventable? Focus on Alzheimer's disease. Expert Review of Neurotherapeutics, 10(11), 1689-1698. doi: 10.1586/ern.10.159

Barak, Y., Bleich, A., & Aizenberg, D. (2010). Psychosocial remission in schizophrenia: Developing a clinician-rated scale. Comprehensive Psychiatry, 51(1), 94-98. doi: 10.1016/j.comppsych.2008.11.013

Barak, Y., & Achiron, A. (2009). Happiness and neurological diseases. Expert Review of Neurotherapeutics, 9(4), 445-459. doi: 10.1586/ern.09.1

Mazeh, D., Bodner, E., Weizman, R., Delayahu, Y., Cholostoy, A., Martin, T., & Barak, Y. (2009). Co-morbid social phobia in schizophrenia. International Journal of Social Psychiatry, 55(3), 198-202. doi: 10.1177/0020764008093447

Wohl, Y., Aviv, A., Friedman, T., & Barak, Y. (2008). Cutaneous photodamage in schizophrenia patients. Photodermatology, Photoimmunology, & Photomedicine, 24(6), 291-295. doi: 10.1111/j.1600-0781.2008.00378.x

Barak, Y. (2008). Breast cancer in women suffering from serious mental illness. Schizophrenia Research, 102(1-3), 249-253. doi: 10.1016/j.schres.2008.03.017

Barak, Y., Baruch, Y., Achiron, A., & Aizenberg, D. (2008). Suicide attempts of schizophrenia patients: A case-controlled study in tertiary care. Journal of Psychiatric Research, 42(10), 822-826. doi: 10.1016/j.jpsychires.2007.09.002

Simeoni, M. C., Auquier, P., Fernandez, O., Flachenecker, P., Stecchi, S., Constantinescu, C. S., … Barak, Y., … Pelletier, J., on behalf of the MusiQoL study group (2008). Validation of the Multiple Sclerosis International Quality of Life questionnaire. Multiple Sclerosis Journal, 14(2), 219-230. doi: 10.1177/1352458507080733

Paleacu, D., Barak, Y., Mirecky, I., & Mazeh, D. (2008). Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: A 6-week, double-blind, placebo-controlled study. International Journal of Geriatric Psychiatry, 23(4), 393-400. doi: 10.1002/gps.1892

Barak, Y. (2008). Co-prescription of antidepressants with other psychotropics: Distinct profile of escitalopram. International Journal of Psychiatry in Clinical Practice, 12(1), 31-35. doi: 10.1080/13651500701419701

Rabinowitz, I., Baruch, Y., & Barak, Y. (2008). High-dose escitalopram for the treatment of obsessive-compulsive disorder. International Clinical Psychopharmacology, 23(1), 49-53. doi: 10.1097/YIC.0b013e3282f0f0c5

Abramowitz, E. G., Barak, Y., Ben-Avi, I., & Knobler, H. Y. (2008). Hypnotherapy in the treatment of chronic combat-related PTSD patients suffering from insomnia: A randomized, Zolpidem-controlled clinical trial. International Journal of Clinical & Experimental Hypnosis, 56(3), 270-280. doi: 10.1080/00207140802039672

Werner, P., Aviv, A., & Barak, Y. (2008). Self-stigma, self-esteem and age in persons with schizophrenia. International Psychogeriatrics, 20(1), 174-187. doi: 10.1017/s1041610207005340

Tadger, S., Baruch, Y., & Barak, Y. (2008). Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone. International Psychogeriatrics, 20(6), 1245-1250. doi: 10.1017/s1041610208007606

Mazeh, D., Shahal, B., Aviv, A., Zemishlani, H., & Barak, Y. (2007). A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression. International Clinical Psychopharmacology, 22(6), 371-375. doi: 10.1097/YIC.0b013e32817396ae

Harel, Y., Barak, Y., & Achiron, A. (2007). Dysregulation of affect in multiple sclerosis: New phenomenological approach. Psychiatry & Clinical Neurosciences, 61(1), 94-98. doi: 10.1111/j.1440-1819.2007.01616.x

Barak, Y. (2007). The aging of Holocaust survivors: Myth and reality concerning suicide. Israel Medical Association Journal, 9(3), 196-198.

Barak, Y., Baruch, Y., Mazeh, D., Paleacu, D., & Aizenberg, D. (2007). Cardiac and cerebrovascular morbidity and mortality associated with antipsychotic medications in elderly psychiatric inpatients. American Journal of Geriatric Psychiatry, 15(4), 354-356. doi: 10.1097/JGP.0b013e318030253a

Mazeh, D., Zemishlani, H., Barak, Y., Mirecki, I., & Paleacu, D. (2006). Donepezil for negative signs in elderly patients with schizophrenia: An add-on, double-blind, crossover, placebo-controlled study. International Psychogeriatrics, 18(3), 429-436. doi: 10.1017/s1041610205003017

Barak, Y., Mazeh, D., Plopski, I., & Baruch, Y. (2006). Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia. American Journal of Geriatric Psychiatry, 14(7), 629-633. doi: 10.1097/01.jgp.0000216325.42721.99

Barak, Y., & Aizenberg, D. (2006). Association between antidepressant prescribing and suicide in Israel. International Clinical Psychopharmacology, 21(5), 281-284.

Barak, Y. (2006). The immune system and happiness. Autoimmunity Reviews, 5(8), 523-527. doi: 10.1016/j.autrev.2006.02.010

Rotstein, Z., Hazan, R., Barak, Y., & Achiron, A. (2006). Perspectives in multiple sclerosis health care: Special focus on the costs of multiple sclerosis. Autoimmunity Reviews, 5(8), 511-516. doi: 10.1016/j.autrev.2006.02.001

Stein, D., Weizman, A., Ring, A., & Barak, Y. (2006). Obstetric complications in individuals diagnosed with autism and in healthy controls. Comprehensive Psychiatry, 47(1), 69-75. doi: 10.1016/j.comppsych.2005.01.001

Friedman, T., Wohl, Y., Knobler, H. Y., Lubin, G., Brenner, S., Levi, Y., & Barak, Y. (2006). Increased use of mental health services related to Isotretinoin treatment: A 5-year analysis. European Neuropsychopharmacology, 16(6), 413-416. doi: 10.1016/j.euroneuro.2005.11.006

Aizenberg, D., Olmer, A., & Barak, Y. (2006). Suicide attempts amongst elderly bipolar patients. Journal of Affective Disorders, 91(1), 91-94. doi: 10.1016/j.jad.2005.12.013

Barak, Y., Olmer, A., & Aizenberg, D. (2006). Antidepressants reduce the risk of suicide among elderly depressed patients. Neuropsychopharmacology, 31(1), 178-181. doi: 10.1038/sj.npp.1300863

Barak, Y., Wohl, Y., Greenberg, Y., Dayan, Y. B., Friedman, T., Shoval, G., & Knobler, H. Y. (2005). Affective psychosis following Accutane (isotretinoin) treatment. International Clinical Psychopharmacology, 20(1), 39-41.

Barak, Y., Aizenberg, D., Szor, H., Swartz, M., Maor, R., & Knobler, H. Y. (2005). Increased risk of attempted suicide among aging Holocaust survivors. American Journal of Geriatric Psychiatry, 13(8), 701-4. doi: 10.1176/appi.ajgp.13.8.701

Barak, Y., Achiron, A., Mandell, M., Mirecki, I., & Aizenberg, D. (2005). Reduced cancer incidence among patients with schizophrenia. Cancer, 104(12), 2817-2821. doi: 10.1002/cncr.21574

Achiron, A., Barak, Y., Gail, M., Mandell, M., Pee, D., Ayyagari, R., & Rotstein, Z. (2005). Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments. Breast Cancer Research & Treatment, 89(3), 265-270. doi: 10.1007/s10549-004-2229-4

Achiron, A., Polliack, M., Rao, S. M., Barak, Y., Lavie, M., Appelboim, N., & Harel, Y. (2005). Cognitive patterns and progression in multiple sclerosis: Construction and validation of percentile curves. Journal of Neurology, Neurosurgery & Psychiatry, 76(5), 744-749. doi: 10.1136/jnnp.2004.045518

Barak, Y., Swartz, M., & Plopsky, I. (2005). Assessing cardiovascular risks of olanzapine treatment: A 6-month study versus haloperidol in schizophrenia patients. International Clinical Psychopharmacology, 20(6), 315-317.

Stein, D., Zemishlani, C., Shahal, B., & Barak, Y. (2005). Disordered eating in elderly female patients diagnosed with chronic schizophrenia. Israel Journal of Psychiatry & Related Sciences, 42(3), 191-197.

Mazeh, D., Zemishlani, C., Aizenberg, D., & Barak, Y. (2005). Patients with very-late-onset schizophrenia-like psychosis: A follow-up study. American Journal of Geriatric Psychiatry, 13(5), 417-419. doi: 10.1176/appi.ajgp.13.5.417

Mazeh, D., Cholostoy, A., Zemishlani, C., & Barak, Y. (2005). Elderly psychiatric patients at risk of folic acid deficiency: A case controlled study. Archives of Gerontology & Geriatrics, 41(3), 297-302. doi: 10.1016/j.archger.2005.04.006

Barak, Y., Shamir, E., Mirecki, I., Weizman, R., & Aizenberg, D. (2004). Switching elderly chronic psychotic patients to olanzapine. International Journal of Neuropsychopharmacology, 7(2), 165-169. doi: 10.1017/s1461145703004048

Barak, Y., Davidson, M., Luxenberg, J. S., & Aizenberg, D. (2004). Psychiatric services in nursing homes in Israel: Should the American legislation be adopted? Israel Journal of Psychiatry & Related Sciences, 41(3), 213-217.

Barak, Y., Mirecki, I., Knobler, H. Y., & Natan, Z. (2004). Suicidality and second generation antipsychotics in schizophrenia patients: A case-controlled retrospective study during a 5-year period. Psychopharmacology, 175(2), 215-219. doi: 10.1007/s00213-004-1801-2

Drimer, T., Shahal, B., & Barak, Y. (2004). Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. International Clinical Psychopharmacology, 19(1), 27-9. doi: 10.1097/01.yic.0000102048.1367.4c

Barak, Y., Cohen, A., & Aizenberg, D. (2004). Suicide among the homeless: A 9-year case-series analysis. Crisis, 25(2), 51-53. doi: 10.1027/0227-5910.25.2.51

Achiron, A., Kishner, I., Sarova-Pinhas, I., Raz, H., Faibel, M., Stern, Y., … Barak, Y. (2004). Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Archives of Neurology, 61(10), 1515-1520. doi: 10.1001/archneur.61.10.1515

Achiron, A., Edelstein, S., Ziev-Ner, Y., Givon, U., Rotstein, Z., & Barak, Y. (2004). Bone strength in multiple sclerosis: Cortical midtibial speed-of-sound assessment. Multiple Sclerosis, 10(5), 488-493. doi: 10.1191/1352458504ms1076oa

Remnik, Y., Melamed, Y., Swartz, M., Elizur, A., & Barak, Y. (2004). Patients' satisfaction with psychiatric inpatient care. Israel Journal of Psychiatry & Related Sciences, 41(3), 208-212.

Barak, Y., Knobler, C. Y., & Aizenberg, D. (2004). Suicide attempts amongst elderly schizophrenia patients: A 10-year case-control study. Schizophrenia Research, 71(1), 77-81. doi: 10.1016/j.schres.2003.12.001

Achiron, A., & Barak, Y. (2003). Cognitive impairment in probable multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 74(4), 443-446. doi: 10.1136/jnnp.74.4.443

Jeste, D. V., Barak, Y., Madhusoodanan, S., Grossman, F., & Gharabawi, G. (2003). International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia. American Journal of Geriatric Psychiatry, 11(6), 638-647.

Aizenberg, D., Weizman, A., & Barak, Y. (2003). Sildenafil for selective serotonin reuptake inhibitor-induced erectile dysfunction in elderly male depressed patients. Journal of Sex & Marital Therapy, 29(4), 297-303. doi: 10.1080/00926230390195533

Barak, Y., & Aizenberg, D. (2003). Effects of olanzapine on lipid abnormalities in elderly psychotic patients. Drugs & Aging, 20(12), 893-896.

Barak, Y., Swartz, M., Levy, D., & Weizman, R. (2003). Age-related differences in the side effect profile of citalopram. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27(3), 545-548. doi: 10.1016/s0278-5846(03)00041-1

Achiron, A., Barak, Y., & Rotstein, Z. (2003). Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis. Multiple Sclerosis, 9(5), 486-491. doi: 10.1191/1352458503ms945oa

Barak, Y., Aizenberg, D., & Achiron, A. (2003). Concordance for cognitive impairment: A study of 50 community-dwelling elderly female-female twin pairs. Comprehensive Psychiatry, 44(2), 117-120. doi: 10.1053/comp.2003.50019

Mazeh, D., Melamed, Y., & Barak, Y. (2003). Emergency psychiatry: Treatment of referred psychiatric patients by general hospital emergency department physicians. Psychiatric Services, 54(9), 1221-1223. doi: 10.1176/

Hadjez, J., Stein, D., Gabbay, U., Bruckner, J., Meged, S., Barak, Y., … Rotenberg, V. S. (2003). Dream content of schizophrenic, nonschizophrenic mentally ill, and community control adolescents. Adolescence, 38(150), 331-342.

Barak, Y., & Cohen, A. (2003). Characterizing the elderly homeless: A 10-year study in Israel. Archives of Gerontology & Geriatrics, 37(2), 147-155.

Barak, Y. (2002). No weight gain among elderly schizophrenia patients after 1 year of risperidone treatment. Journal of Clinical Psychiatry, 63(2), 117-119.

Nachman, R., Yanai, O., Goldin, L., Swartz, M., Barak, Y., & Hiss, J. (2002). Suicide in Israel: 1985-1997. Journal of Psychiatry & Neuroscience, 27(6), 423-428.

Barak, Y., Aizenberg, D., Mirecki, I., Mazeh, D., & Achiron, A. (2002). Very late-onset schizophrenia-like psychosis: Clinical and imaging characteristics in comparison with elderly patients with schizophrenia. Journal of Nervous & Mental Disease, 190(11), 733-736. doi: 10.1097/01.nmd.0000038167.15155.d6

Barak, Y., Shamir, E., & Weizman, R. (2002). Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study. Journal of Clinical Psychopharmacology, 22(2), 115-120.

Rotenberg, V. S., Shamir, E., Barak, Y., Indursky, P., Kayumov, L., & Mark, M. (2002). REM sleep latency and wakefulness in the first sleep cycle as markers of major depression: A controlled study vs. schizophrenia and normal controls. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26(6), 1211-1215. doi: 10.1016/S0278-5846(02)00216-6

Barak, Y., & Aizenberg, D. (2002). Suicide amongst Alzheimer's disease patients: A 10-year survey. Dementia & Geriatric Cognitive Disorders, 14(2), 101-103. doi: 10.1159/000064931

Barak, Y., & Achiron, A. (2002). Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. European Neurology, 47(1), 11-14. doi: 10.1159/000047940

Stein, D., Pat-Horenczyk, R., Blank, S., Dagan, Y., Barak, Y., & Gumpel, T. P. (2002). Sleep disturbances in adolescents with symptoms of attention-deficit/hyperactivity disorder. Journal of Learning Disabilities, 35(3), 268-275. doi: 10.1177/002221940203500308

Aizenberg, D., Sigler, M., Weizman, A., & Barak, Y. (2002). Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: A 4-year case-control study. International Psychogeriatrics, 14(3), 307-310.

Barak, Y., Shamir, E., Zemishlani, H., Mirecki, I., Toren, P., & Weizman, R. (2002). Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26(6), 1199-1202.

Paleacu, D., Mazeh, D., Mirecki, I., Even, M., & Barak, Y. (2002). Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease. Clinical Neuropharmacology, 25(6), 313-317.

Barak, Y., Lavie, M., & Achiron, A. (2002). Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test. Journal of Clinical Neuroscience, 9(6), 629-632. doi: 10.1054/jocn.2002.1110

Milstein, A., Pollack, A., Kleinman, G., & Barak, Y. (2002). Confusion/delirium following cataract surgery: An incidence study of 1-year duration. International Psychogeriatrics, 14(3), 301-306. doi: 10.1017/S1041610202008499

Barak, Y., Bodner, E., Zemishlani, H., Mirecki, I., & Aizenberg, D. (2001). Donepezil for the treatment of behavioral disturbances in Alzheimer's disease: A 6-month open trial. Archives of Gerontology & Geriatrics, 33(3), 237-241. doi: 10.1016/S0167-4943(01)00187-X

Polliack, M. L., Barak, Y., & Achiron, A. (2001). Late-onset multiple sclerosis. Journal of the American Geriatrics Society, 49(2), 168-171. doi: 10.1046/j.1532-5415.2001.49038.x

Barak, Y., Savorai, O., Mavashev, S., & Beni, A. (2001). Animal-assisted therapy for elderly schizophrenic patients: A one-year controlled trial. American Journal of Geriatric Psychiatry, 9(4), 439-442. doi: 10.1097/00019442-200111000-00013

Stein, D., Ring, A., Shulman, C., Meir, D., Holan, A., Weizman, A., & Barak, Y. (2001). Brief report: Children with autism as they grow up: Description of adult inpatients with severe autism. Journal of Autism & Developmental Disorders, 31(3), 355-360.

More publications...